Hans Denison

Biopharmaceuticals R&D
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.

Journal: BMJ neurology open
Published: June 19, 2023

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.

Journal: Neurology
Published: September 23, 2021

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

Journal: Stroke
Published: September 03, 2021

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.

Journal: JAMA neurology
Published: July 10, 2021

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.

Journal: Stroke
Published: November 17, 2020

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.

Journal: JAMA neurology
Published: November 07, 2020

Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.

Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.

Journal: Clinical trials (London, England)
Published: July 16, 2020

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.

Journal: The New England journal of medicine
Published: July 16, 2020

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.

Journal: International journal of stroke : official journal of the International Stroke Society
Published: May 17, 2019

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.

Journal: Stroke
Published: February 20, 2019

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.

Journal: International journal of stroke : official journal of the International Stroke Society
Published: February 13, 2019

Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial.

Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial.

Journal: Neurology
Published: August 12, 2018
Showing 1-12 of 21

Last Updated: 09/26/2026